Shengjuan Hu

461 total citations
23 papers, 269 citations indexed

About

Shengjuan Hu is a scholar working on Molecular Biology, Epidemiology and Hepatology. According to data from OpenAlex, Shengjuan Hu has authored 23 papers receiving a total of 269 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Epidemiology and 6 papers in Hepatology. Recurrent topics in Shengjuan Hu's work include Liver Disease Diagnosis and Treatment (6 papers), Cancer-related gene regulation (6 papers) and Liver Disease and Transplantation (5 papers). Shengjuan Hu is often cited by papers focused on Liver Disease Diagnosis and Treatment (6 papers), Cancer-related gene regulation (6 papers) and Liver Disease and Transplantation (5 papers). Shengjuan Hu collaborates with scholars based in China. Shengjuan Hu's co-authors include Huahong Xie, Daiming Fan, Ming Luo, Liu Hong, Feihu Bai, Yulei Du, Kaichun Wu, Yanglin Pan, Hongwei Tang and Xiaoxuan Ning and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Antimicrobial Agents and Chemotherapy and World Journal of Gastroenterology.

In The Last Decade

Shengjuan Hu

23 papers receiving 266 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shengjuan Hu China 10 159 69 58 48 43 23 269
Fung Yu Huang Hong Kong 5 154 1.0× 61 0.9× 56 1.0× 161 3.4× 109 2.5× 6 376
Karel P. Alcedo United States 10 185 1.2× 53 0.8× 48 0.8× 54 1.1× 13 0.3× 10 367
Tingyi Sun China 10 202 1.3× 139 2.0× 22 0.4× 30 0.6× 17 0.4× 22 333
Paulina Węgrzyn Poland 10 209 1.3× 80 1.2× 49 0.8× 47 1.0× 11 0.3× 13 362
Oda M Japan 7 161 1.0× 70 1.0× 75 1.3× 39 0.8× 35 0.8× 52 325
Xiaoyu Zhao China 10 144 0.9× 71 1.0× 70 1.2× 17 0.4× 21 0.5× 30 292
Shruti Sinha India 11 124 0.8× 57 0.8× 49 0.8× 19 0.4× 12 0.3× 26 264
Jianxin Wu China 7 157 1.0× 46 0.7× 16 0.3× 54 1.1× 78 1.8× 13 260

Countries citing papers authored by Shengjuan Hu

Since Specialization
Citations

This map shows the geographic impact of Shengjuan Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengjuan Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengjuan Hu more than expected).

Fields of papers citing papers by Shengjuan Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengjuan Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengjuan Hu. The network helps show where Shengjuan Hu may publish in the future.

Co-authorship network of co-authors of Shengjuan Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Shengjuan Hu. A scholar is included among the top collaborators of Shengjuan Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengjuan Hu. Shengjuan Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Li, Ximei, et al.. (2023). Krüppel‐Like Factor 2 Is a Gastric Cancer Suppressor and Prognostic Biomarker. Evidence-based Complementary and Alternative Medicine. 2023(1). 2360149–2360149. 1 indexed citations
3.
Li, Ximei, et al.. (2023). Esophageal cancer-related gene 4 inhibits gastric cancer growth and metastasis by upregulating Krüppel-like factor 2 expression. Annals of Translational Medicine. 11(4). 176–176. 1 indexed citations
4.
Luo, Ming, et al.. (2023). Role of gut microbiota in the pathogenesis and therapeutics of minimal hepatic encephalopathy via the gut-liver-brain axis. World Journal of Gastroenterology. 29(1). 144–156. 23 indexed citations
5.
Lei, Hui, et al.. (2023). Primary symptoms of severe mycoplasma pneumoniae pneumonia with acute abdomen, scrotal swelling and pain, and fever: A case report. Immunity Inflammation and Disease. 11(10). e955–e955. 1 indexed citations
6.
Luo, Ming, et al.. (2022). Altered gut microbiota is associated with sleep disturbances in patients with minimal hepatic encephalopathy caused by hepatitis B-related liver cirrhosis. Expert Review of Gastroenterology & Hepatology. 16(8). 797–807. 4 indexed citations
7.
Luo, Ming, et al.. (2022). EncephalApp stroop test versus electronic number connection test-A for screening minimal hepatic encephalopathy in patients with liver cirrhosis: a comparative study. Scandinavian Journal of Gastroenterology. 57(9). 1066–1069. 5 indexed citations
8.
You, Yanjie & Shengjuan Hu. (2022). Aberrant expression of the esophageal carcinoma related gene 4 as a prognostic signature for hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology. 46(5). 101891–101891. 1 indexed citations
9.
Hu, Shengjuan, Jing Wang, Yanhong Deng, et al.. (2022). A Survey of Helicobacter pylori Antibiotic-Resistant Genotypes and Strain Lineages by Whole-Genome Sequencing in China. Antimicrobial Agents and Chemotherapy. 66(6). e0218821–e0218821. 17 indexed citations
10.
You, Yanjie & Shengjuan Hu. (2021). Dysregulation of ECRG4 is associated with malignant properties and of prognostic importance in human gastric cancer. Cancer Biomarkers. 34(1). 55–66. 2 indexed citations
11.
Hu, Shengjuan, Jianguo Niu, Rong Zhang, et al.. (2020). Orexin A associates with inflammation by interacting with OX1R/OX2R receptor and activating prepro-Orexin in cancer tissues of gastric cancer patients. Gastroenterología y Hepatología (English Edition). 43(5). 240–247. 1 indexed citations
12.
Hu, Shengjuan, Jianguo Niu, Rong Zhang, et al.. (2020). Orexin A associates with inflammation by interacting with OX1R/OX2R receptor and activating prepro-Orexin in cancer tissues of gastric cancer patients. Gastroenterología y Hepatología. 43(5). 240–247. 9 indexed citations
13.
Bai, Feihu, Ming Luo, Xiaobing Yu, & Shengjuan Hu. (2020). EncephalApp Stroop App predicts poor sleep quality in patients with minimal hepatic encephalopathy due to hepatitis B-induced liver cirrhosis. Saudi Journal of Gastroenterology. 26(3). 120–120. 6 indexed citations
14.
Yin, Jipeng, Xiu‐He Lv, Shengjuan Hu, et al.. (2018). Overexpression of serum response factor is correlated with poor prognosis in patients with gastric cancer. Human Pathology. 85. 10–17. 9 indexed citations
15.
Luo, Ming, Han Liu, Shengjuan Hu, & Feihu Bai. (2015). Potential targeted therapies for the inflammatory pathogenesis of hepatic encephalopathy. Clinics and Research in Hepatology and Gastroenterology. 39(6). 665–673. 12 indexed citations
16.
Xie, Huahong, Jiugang Song, Kaige Liu, et al.. (2008). The Expression of Hypoxia-Inducible Factor-1α in Hepatitis B Virus-Related Hepatocellular Carcinoma: Correlation with Patients’ Prognosis and Hepatitis B Virus X Protein. Digestive Diseases and Sciences. 53(12). 3225–3233. 43 indexed citations
17.
Du, Yulei, Fang Yin, Changjiang Liu, et al.. (2006). Depression of MAD2 inhibits apoptosis of gastric cancer cells by upregulating Bcl-2 and interfering mitochondrion pathway. Biochemical and Biophysical Research Communications. 345(3). 1092–1098. 28 indexed citations
18.
Hu, Shengjuan, Huahong Xie, Yulei Du, et al.. (2006). Phage display selection of peptides that inhibit metastasis ability of gastric cancer cells with high liver-metastatic potential. Biochemical and Biophysical Research Communications. 341(4). 964–972. 28 indexed citations
19.
Zhai, Huihong, Yongquan Shi, Jinhua Yu, et al.. (2006). Establishment and Characterization of Calcyclin Binding Protein (CacyBP) Monoclonal Antibody. Hybridoma. 25(2). 91–94. 11 indexed citations
20.
Wang, Jun, Kaichun Wu, Dexin Zhang, et al.. (2005). Expressions and clinical significances of angiopoietin-1, -2 and Tie2 in human gastric cancer. Biochemical and Biophysical Research Communications. 337(1). 386–393. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fung Yu Huang Breakdown of academic impact, for papers by Karel P. Alcedo Breakdown of academic impact, for papers by Tingyi Sun Breakdown of academic impact, for papers by Paulina Węgrzyn Breakdown of academic impact, for papers by Oda M Breakdown of academic impact, for papers by Xiaoyu Zhao Breakdown of academic impact, for papers by Shruti Sinha Breakdown of academic impact, for papers by Jianxin Wu
Rankless by CCL
2026